OMS · OMS112831
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A randomized, double-blind, placebo-controlled, parallel-group study to investigate the MRI-based efficacy and safety of ofatumumab administration over six months in patients with relapsing-remitting multiple sclerosis. EudraCT: 2011-002333-19
Sponsor: GLAXOSMITHKLINE
Phase: II
Area: Neuroimmunology